Psychedelic Science 2023

Be Part of

        the Breakthrough

Presented by

Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study

PS2023-233-tn

Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study

This study aims to investigate the effects of oral psilocybin on OCD symptomatology and provide the first evidence of the neural mechanism that may mediate psilocybin's purported therapeutic effects on OCD. https://clinicaltrials.gov/ct2/show/NCT03356483

Share: Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study

Facebook
Twitter
LinkedIn
Email

Already Registered?

If you already registered for the in-person portion of the Psychedelic Science 2023 conference, get immediate access to PS2023: The Virtual Trip by logging in with the email address you used when signing up for the conference. We’ll email you a login link—no password necessary!

Need to Register?

If you are not yet registered for Psychedelic Science 2023, you can sign up for PS2023: The Virtual Trip access by creating an account.